Evidences for B6C3-Tg (APPswe/PSEN1dE9) double-transgenic mice between 3 and 10 months as an age-related Alzheimer's disease model

Journal of Molecular Neuroscience

Volumn 53, Issue 3, 2014, Pages 370-376

  Zhong, Zhiyong ^a,b   Yang, Lin ^b   Wu, Xiansheng ^b   Huang, Wei ^b   Yan, Jiarong ^b   Liu, Shenglai ^b   Sun, Xia ^b   Liu, Ke ^b   Lin, Huangquan ^c   Kuang, Shaosong ^b   Tang, Xiaojiang ^a,b  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b Guangdong Medical Laboratory Animal Center   (China)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

AChE activity; Alzheimer's disease; Memory loss; Transgenic mice; Amyloid plaque

Indexed keywords

ACETYLCHOLINESTERASE; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; PRESENILIN 1; PRESENILIN 1, MOUSE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; IMMUNOHISTOCHEMISTRY; LATENT PERIOD; LEARNING; MALE; MEMORY; MORRIS WATER MAZE TEST; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; SPATIAL LEARNING; TRANSGENIC MOUSE; AGE; AMYLOID PLAQUE; ANIMAL; BRAIN; C57BL MOUSE; ENZYMOLOGY; GENETICS; MAZE TEST; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY;

MUS; MUS MUSCULUS;

ACETYLCHOLINESTERASE; AGE FACTORS; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BRAIN; MALE; MAZE LEARNING; MICE; MICE, INBRED C57BL; PLAQUE, AMYLOID; PRESENILIN-1;

EID: 84904987120     PISSN: 08958696     EISSN: 15591166     Source Type: Journal    
DOI: 10.1007/s12031-013-0203-5     Document Type: Article

References (19)

1. Anand P, Singh B (2013) A review on cholinesterase inhibitors for Alzheimer's disease. Arch Pharm Res 36:75-399
2. Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM (2007) Forecasting the global burden of Alzheimer's disease. Alzheimers Dement 3:186-191 (Pubitemid 46825511)
3. Chapman PF, Falinska AM, Knevet SG, Ramsay MF (2001) Genes, models and Alzheimer's disease. Trends Genet 17:254-261 (Pubitemid 32378748)
4. Cummings JL, Banks SJ, Gary RK, Kinney JW, Lombardo JM, Walsh RR, Zhong K (2013) Alzheimer's disease drug development: translational neuroscience strategies. CNS Spectr 18:128- 138
5. Hock BJ, Lamb JT, Lamb BT (2001) Transgenic mouse models of Alzheimer's disease. Trends Genet 17:7-12
6. Hu{combining double acute accent}ll M, Berger M, Heneka M (2006) Disease-modifying therapies in Alzheimer's disease: how far have we come? Drugs 66:2075-2093
7. Jankowsky JL, Slunt HH, Ratovitski T, Jenkins NA, Copeland NG, Borchelt DR (2001) Co-expression of multiple transgenes in mouse CNS: a comparison of strategies. Biomol Eng 17:157-165 (Pubitemid 32409891)
8. Kovács T (2009) Therapy of Alzheimer disease. Neuropsychopharmacol Hung 11:27-33
9. Lane RM, Potkin SG, Enz A (2006) Targeting acetylcholinesterase and butyrylcholinesterase in dementia. Int J Neuropsychopharmacol 9:101-124 (Pubitemid 43068340)
10. Pillai JA, Cummings JL (2013) Clinical trials in predementia stages of Alzheimer disease. Med Clin N Am 97:439-457
11. Rees T, Hammond PI, Soreq H, Younkin S, Brimijoin S (2003) Acetylcholinesterase promotes beta-amyloid plaques in cerebral cortex. Neuobiol Aging 24:777-787 (Pubitemid 37288853)
12. Salomone S, Caraci F, Leggio GM, Fedotova J, Drago F (2012) New pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugs. Br J Clin Pharmacol 73:504-517
13. Schneider LS (2013) Alzheimer disease pharmacologic treatment and treatment research. Continuum 19:339-357
14. Selkoe DJ (2001) Alzheimer's disease: gene, proteins, and therapy. Physiol Rev 81:741-766
15. Sturchler-Pierrat C, Abramowski D, Duke M, Wiederhould KH, Mistl C, Rothacher S et al (1997) Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc Natl Acad Sci 94:13287-13292 (Pubitemid 27518514)
16. Tang JX, Eckenhoff MF (2012) Anesthetic effect in Alzheimer transgenic mouse models. Prog Neuro-Psychopharmacol Biol Psychiatry. doi:10.1016/j.pnpbp. 2012.06.007
17. Ulrich J, Meier-Ruge W, Probst A, Meier E, Ipsen S (1990) Senile plaques: staining for acetylcholinesterase and A4 protein: a comparative study in the hippocampus and entorhinal cortex. Acta Neuropathol 86:624-628 (Pubitemid 20342503)
18. Zhang Q, Zhang X, Chen J, Miao Y, Sun A (2009a) Role of caspase-3 in tau truncation at D421 is restricted in transgenic mouse models for tauopathies. J Neurochem 109:476-484, 94, 13287-13292
19. Zhang Q, Zhang X, Chen J, Miao Y, Sun A (2009b) Role of caspase-3 in tau truncation at D421 is restricted in transgenic mouse models for tauopathies. J Neurochem 109:476-484